BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38698330)

  • 1. Sesamolin serves as an MYH14 inhibitor to sensitize endometrial cancer to chemotherapy and endocrine therapy via suppressing MYH9/GSK3β/β-catenin signaling.
    Lin Y; Chen X; Lin L; Xu B; Zhu X; Lin X
    Cell Mol Biol Lett; 2024 May; 29(1):63. PubMed ID: 38698330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
    Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
    Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
    Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
    [No Abstract]   [Full Text] [Related]  

  • 4. miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.
    Liu L; Ning Y; Yi J; Yuan J; Fang W; Lin Z; Zeng Z
    Biomed Pharmacother; 2020 May; 125():109865. PubMed ID: 32058212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling.
    Gao S; Wang S; Zhao Z; Zhang C; Liu Z; Ye P; Xu Z; Yi B; Jiao K; Naik GA; Wei S; Rais-Bahrami S; Bae S; Yang WH; Sonpavde G; Liu R; Wang L
    Nat Commun; 2022 May; 13(1):2792. PubMed ID: 35589707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.
    Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W
    EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting Wnt/beta-catenin in CTNNB1-mutated endometrial cancer.
    Moroney MR; Woodruff E; Qamar L; Bradford AP; Wolsky R; Bitler BG; Corr BR
    Mol Carcinog; 2021 Aug; 60(8):511-523. PubMed ID: 34038589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
    Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
    IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
    Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
    EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma.
    Lin X; Chen J; Li X; Chen D; Luo K; Deng Y; Yang D; Huang Z; Tao C
    Arch Toxicol; 2023 Jun; 97(6):1627-1647. PubMed ID: 37120773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIF15 knockdown inhibits the development of endometrial cancer by suppressing epithelial-mesenchymal transition and stemness through Wnt/β-catenin signaling.
    Huang J; Sun X; Diao G; Li R; Guo J; Han J
    Environ Toxicol; 2023 Aug; 38(8):1824-1834. PubMed ID: 37186152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 13. Circ_0109046 promotes the malignancy of endometrial carcinoma cells through the microRNA-105/SOX9/Wnt/β-catenin axis.
    Li Y; Liu J; Piao J; Ou J; Zhu X
    IUBMB Life; 2021 Jan; 73(1):159-176. PubMed ID: 33220169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway.
    Xu Y; Hu J; Lv Q; Shi C; Qiu M; Xie L; Liu W; Yang B; Shan W; Cheng Y; Zhao B; Chen X
    Stem Cell Res Ther; 2023 Jun; 14(1):159. PubMed ID: 37287079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZNF554 Inhibits Endometrial Cancer Progression via Regulating RBM5 and Inactivating WNT/β-Catenin Signaling Pathway.
    Zhu CC; Sun HL; Long TF; Lyu YY; Liu JL; Ni GT
    Curr Med Sci; 2024 Apr; 44(2):406-418. PubMed ID: 38619681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
    Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
    Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3β/β-Catenin Signaling.
    Li Q; Luo H; Dai FQ; Wang RT; Fan XQ; Luo YY; Deng MS; Wang Y; Long T; Guo W; Xu B; Xu CX; Jin H
    Adv Sci (Weinh); 2023 Apr; 10(11):e2203573. PubMed ID: 36757050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma.
    Guo L; Chen H; Chen J; Gao C; Fu X; Zhou S; Wu W; Li T; Lin J; Yang T; Chen Z; Cao L
    Tissue Cell; 2023 Jun; 82():102083. PubMed ID: 37054536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.
    Liu XF; Li XY; Zheng PS; Yang WT
    Cell Death Dis; 2018 Mar; 9(3):339. PubMed ID: 29497051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
    Li Y; Wang Y; Zou Q; Li S; Zhang F
    Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.